Molecular characterization of five neutralizing anti-HIV type 1 antibodies: Identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5

AIDS Research and Human Retroviruses

Volumn 14, Issue 13, 1998, Pages 1115-1128

  Kunert, Renate ^a   Rüker, Florian ^a   Katinger, Hermann ^a  

^a UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIGEN P24; COMPLEMENTARY DNA; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; NEUTRALIZING ANTIBODY; NUCLEOTIDE; RNA;

AMINO ACID SEQUENCE; ARTICLE; GENE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SOMATIC MUTATION;

EID: 0032167410     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.1115     Document Type: Article

References (54)

1. Ho DD, Fung MS, Cao YZ, Li XL, Sun C, Chang TW, and Sun NC: Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody. Proc Natl Acad Sci USA 1991;88:8949-8952.
2. Karwowska S, Gorny MK, Buchbinder A, Gianakakos V, Williams C, Fuerst T, and Zolla-Pazner S: Production of human monoclonal antibodies specific for conformational and linear non-V3 epitopes of gp120. AIDS Res Hum Retroviruses 1992;8:1099-1106.
3. Buchacher A, Predl R, Strutzenberger K, Steinfellner W, Trkola A, Purtscher M, Gruber G, Tauer C, Steindl F, and Jungbauer A: Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res Hum Retroviruses 1994;10:359-369.
4. Purtscher M, Trkola A, Gruber G, Buchacher A, Predl R, Steindl F, Tauer C, Berger R, Barrett N, and Jungbauer A: A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1994;10:1651-1658.
5. Trkola A, Pomales AB, Yuan H, Korber B, Maddon PJ, Allaway GP, Katinger H, Barbas CF III, Burton DR, and Ho DD: Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J Virol 1995;69:6609-6617.
6. Muster T, Guinea R, Trkola A, Purtscher M, Klima A, Steindl F, Palese P, and Katinger H: Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS. J Virol 1994;68:4031-4034.
7. Conley AJ, Kessler JA II, Boots LJ, Tung JS, Arnold BA, Keller PM, Shaw AR, and Emini EA: Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody. Proc Natl Acad Sci USA 1994;91:3348-3352.
8. Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N, Srinivasan K, Sodroski J, Moore JP, and Katinger H: Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 1996;70:1100-1108.
9. Moore JP and Sodroski J: Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. J Virol 1996;70:1863-1872.
10. Mascola JR, Louder MK, VanCott TC, Sapan CV, Lambert JS, Muenz LR, Bunow B, Birx DL, and Robb ML: Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12. J Virol 1997;71:7198-7206.
11. Li A, Baba TW, Sodroski J, Zolla-Pazner S, Gorny MK, Robinson J, Posner MR, Katinger H, Barbas CF III, Burton DR, Chou TC, and Ruprecht R: Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins. AIDS Res Hum Retroviruses 1997;13:647-656.
12. + by triple and quadruple combinations of human monoclonal antibodies and high titer anti-human immunodeficiency virus type 1 immunoglobulins. J Virol 1998;72:3235-3240.
13. Muster T, Ferko B, Klima A, Purtscher M, Trkola A, Schulz P, Grassauer A, Engelhardt OG, Garcia-Sastre A, and Palese P: Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J Virol 1995;69: 6678-6686.
14. Stoiber H, Pinter C, Siccardi AG, Clivio A, and Dierich MP: Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J Exp Med 1996; 183:307-310.
15. Stoiber H, Schneider R, Janatova J, and Dierich MP: Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1. Immunobiology 1995;193:98-113.
16. Grunow R, Jahn S, Porstmann T, Kiessig SS, Steinkellner H, Steindl F, Mattanovich D, Gurtler L, Deinhardt F, and Katinger H: The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus. J Immunol Methods 1998;106:257-265.
17. Sambrook J, Fritsch E, and Maniatis T: Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1991.
18. Marks JD, Tristem M, Karpas A, and Winter G: Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes. Eur J Immunol 1991;21:985-991.
19. Felgenhauer M, Kohl J, and Ruker F: Nucleotide sequences of the cDNAs encoding the V-regions of H- and L-chains of a human monoclonal antibody specific to HIV-1-gp41. Nucleic Acids Res 1990;18:4927.
20. Pearson WR and Lipman DJ: Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 1988;85:2444-2448.
21. Pearson WR: Rapid and sensitive sequence comparison with FASTP and FASTA. Methods Enzymol 1990;183:63.
22. Altschul SF, Gish W, Miller W, Myers EW, and Lipman DJ: Basic local alignment search tool. J Mol Biol 1990;215:403-410.
23. Kabat EA, Wu T, Perra H, Gottesmann K, and Foeller C: Sequences of Proteins of Immunological Interest, 5th Ed., Public Health Service, NIH, Washington DC, 1991.
24. Tomlinson IM, Walter G, Marks JD, Llewelyn MB, and Winter G: The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol 1992;227:776-798.
25. Andris JS, Brodeur BR, and Capra JD: Molecular characterization of human antibodies to bacterial antigens: Utilization of the less frequently expressed VH2 and VH6 heavy chain variable region gene families. Mol Immunol 1993;30:1601-1616.
26. Straubinger B, Huber E, Lorenz W, Osterholzer E, Pargent W, Pech M, Pohlenz HD, Zimmer FJ, and Zachau HG: The human VK locus. Characterization of a duplicated region encoding 28 different immunoglobulin genes. J Mol Biol 1988;199:23-34.
27. Cox JP, Tomlinson IM, and Winter G: A directory of human germline V kappa segments reveals a strong bias in their usage. Eur J Immunol 1994;24:827-836.
28. Pech M and Zachau HG: Immunoglobulin genes of different subgroups are interdigitated within the VK locus. Nucleic Acids Res 1984;12:9229-9236.
29. Huber C, Schable KF, Huber E, Klein R, Meindl A, Thiebe R, Lamm R, and Zachau HG: The V kappa genes of the L regions and the repertoire of V kappa gene sequences in the human germ line. Eur J Immunol 1993;23:2868-2875.
30. Bentley DL and Rabbits TH: Human immunoglobulin variable region genes - DNA sequences of two V kappa genes and a pseudogene. Nature (London) 1980;288:730-733.
31. Jukes TH and King JL: Evolutionary nucleotide replacements in DNA. Nature (London) 1979;281:605-606.
32. Shlomchik MJ, Nemazee DA, Sato VL, Van Snick J, Carson DA, and Weigert MG: Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells. J Exp Med 1986;164:407-427.
33. Yamada M, Wasserman R, Reichard BA, Shane S, Caton AJ, and Rovera G: Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J Exp Med 1991;173:395-407.
34. van der Donk EM, Schutten M, Osterhaus AD, and van der Heijden RW: Molecular characterization of variable heavy and light chain regions of five HIV type 1-specific human monoclonal antibodies. AIDS Res Hum Retroviruses 1994;10:1639-1649.
35. Moran MJ, Andris JS, Matsumato Y, Capra JD, and Hersh EM: Variable region genes of anti-HIV human monoclonal antibodies: Non-restricted use of the V gene repertoire and extensive somatic mutation. Mol Immunol 1993;30:1543-1551.
36. Marasco WA, Bagley J, Zani C, Posner M, Cavacini L, Haseltine WA, and Sodroski J: Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody. J Clin Invest 1992;90:1467-1478.
37. Burton DR, Barbas CF III, Persson MA, Koenig S, Chanock RM, and Lerner RA: A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci USA 1991;88:10134-10137.
38. Pinter A, Honnen WJ, and Tilley SA: Conformational changes affecting the V3 and CD4-binding domains of human immunodeficiency virus type 1 gp120 associated with Env processing and with binding of ligands to these sites. J Virol 1993;67:5692-5697.
39. Barbas CF III, Hu D, Dunlop N, Sawyer L, Cababa D, Hendry RM, Nara PL, and Burton DR: In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. Proc Natl Acad Sci USA 1994;91:3809-3813.
40. Bagley J, Dillon PJ, Rosen C, Robinson J, Sodroski J, and Marasco WA: Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120. Mol Immunol 1994;31:1149-1160.
41. Cook GP, Tomlinson IM, Walter G, Riethman H, Carter NP, Buluwela L, Winter G, and Rabbitts TH: A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. Nature Genet 1994;7:162-168.
42. Milner EC, Hufnagle WO, Glas AM, Suzuki I, and Alexander C: Polymorphism and utilization of human VH Genes. Ann NY Acad Sci 1995;764:50-61.
43. Berman JE, Mellis SJ, Pollock R, Smith CL, Suh H, Heinke B, Kowal C, Surti U, Chess L, and Cantor CR: Content and organization of the human Ig VH locus: Definition of three new VH families and linkage to the Ig CH locus. EMBO J 1988;7:727-738.
44. Huang SC, Jiang R, Glas AM, and Milner EC: Non-stochastic utilization of Ig V region genes in unselected human peripheral B cells. Mol Immunol 1996;33:553-560.
45. Muller S and Kohler H: B cell superantigens in HIV-1 infection. Int Rev Immunol 1997;14:339-349.
46. David D, Goossens D, Desgranges C, Theze J, and Zouali M: Molecular characterization of human monoclonal antibodies specific for several HIV proteins: Analysis of the VH3 family expression. Immunol Lett 1995;47:107-112.
47. Wisnewski A, Cavacini L, and Posner M: Human antibody variable region gene usage in HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:31-38.
48. Silberstein LE, Jefferies LC, Goldman J, Friedman D, Moore JS, Nowell PC, Roelcke D, Pruzanski W, Roudier J, and Silverman GJ: Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood 1991;78:2372-2386.
49. Adderson EE, Shackelford PG, Quinn A, Wilson PM, Cunningham MW, Insel RA, and Carroll WL: Restricted immunoglobulin VH usage and VDJ combinations in the human response to Haemophilus influenzae type b capsular polysaccharide. Nucleotide sequences of monospecific anti-Haemophilus antibodies and polyspecific antibodies cross-reacting with self antigens. J Clin Invest 1993;91:2734-2743.
50. Andris JS, Johnson S, Zolla-Pazner S, and Capra JD: Molecular characterization of five human anti-human immunodeficiency virus type 1 antibody heavy chains reveals extensive somatic mutation typical of an antigen-driven immune response. Proc Natl Acad Sci USA 1991;88:7783-7787.
51. Meek KD, Hasemann CA, and Capra JD: Novel rearrangements at the immunoglobulin D locus. Inversions and fusions add to IgH somatic diversity. J Exp Med 1989;170:39-57.
52. Sanz I, Wang SS, Meneses G, and Fischbach M: Molecular characterization of human Ig heavy chain DIR genes. J Immunol 1994;152:3958-3969.
53. Tomlinson IM, Cook GP, Carter NP, Elaswarapu R, Smith S, Walter G, Buluwela L, Rabbitts TH, and Winter G: Human immunoglobulin VH and D segments on chromosomes 15q11.2 and 16p11.2. Hum Mol Genet 1994;3:853-860.
54. Corbett SJ, Tomlinson IM, Sonnhammer ELL, Buck D, and Winter G: Sequence of the human immunoglobulin diversity (D) segment locus: A systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. J Mol Biol 1997;270:587-597.